Acromegalic arthropathy

Pituitary

Volumn 4, Issue 4, 2001, Pages 263-264

  Barkan, Ariel L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; COXITIS; HUMAN; HYPOPHYSIS TUMOR; JOINT LAXITY; KNEE ARTHRITIS; LIGAMENT DISEASE; OSTEOARTHRITIS; OSTEOARTHROPATHY; OSTEOPHYTE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SYNOVITIS;

ACROMEGALY; ANIMALS; GROWTH HORMONE; HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JOINT DISEASES; OCTREOTIDE;

EID: 0035470160     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020754615863     Document Type: Article

References (13)

1. Detenbeck LC, Tressler HA, O'Duffy JD, Randall RV. Peripheral joint manifestations of acromegaly. Clin Orthop 1973;91:119-127.
2. Podgorski M, Robinson B, Weissberger A, Stiel J, Wang S, Brooks PM. Articular manifestations of acromegaly. Aust N Z J Med 1988;18:28-35.
3. Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH. Acromegalic arthropathy. Characteristics and response to therapy. Arthritis Rheum 1988;31:1022-1027.
4. Okazaki K, Jingushi S, Ikenoue T, Urabe K, Sakai H, Ohtsuru A, Akino K, Yamashita S, Nomura S, Iwamoto Y. Expression of insulin-like growth factor 1 messenger ribonucleic acid in developing osteophytes in murine experimental osteoarthritis and in rats inoculated with growth hormone-secreting tumor. Endocrinology 1999;140:4821-4830.
5. Peterson ME, Taylor RS, Greco DS, Nelson RW, Randolph JF, Foodman MS, Moroff SD, Morrison SA, Lothrop CD. Acromegaly in 14 cats. J Vet Intern Med 1990;4:192-201.
6. Bagge E, Eden S, Rosen T, Bengtsson BA. The prevalence of radiographic osteoarthritis is low in elderly patients with growth hormone deficiency. Acta Endocrinol 1993;129:296-300.
7. Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P. Arthropathy in acromegalic patients before and after treatment: A long-term follow-up study. Clin Endocrinol 1988;28:515-524.
8. Chipman JJ, Attanasio AF, Birkett MA, Bates PC, Webb S, Lamberts SW. The safety profile of GH replacement therapy in adults. Clin Endocrinol 1997;46:473-481.
9. Johanson NA, Vigorita VJ, Goldman AB, Salvati EA. Acromegalic arthropathy of the hip. Clin Orthop 1983;173:130-139.
10. Lacks S, Jacobs RP. Acromegalic arthropathy: A reversible rheumatic disease. J Rheumatol 1986;13:634-636.
11. Roelfsema F, van Dulken H, Frolich M. Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol 1985;23:555-565.
12. Colao A, Marzullo P, Vallone G, Marino V, Annecchino M, Ferone D, De Brasi D, Scarpa R, Oriente P, Lombardi G. Reversibility of joint thickening in acromegalic patients: An ultrasonography study. J Clin Endocrinol Metab 1998;83:2121-2125.
13. Colao A, Marzullo P, Vallone G, Giaccio A, Ferone D, Rossi E, Scarpa R, Smaltino F, Lombardi G. Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months. Clin Endocrinol 1999;51:611-618.